Johnson & Johnson
Change company Symbol lookup
Select an option...
JNJ Johnson & Johnson
AHL-C Aspen Insurance Holdings Ltd
TPIC TPI Composites Inc
ALL Allstate Corp
ATEX Anterix Inc
ALKT Alkami Technology Inc
PSX Phillips 66
PSA Public Storage
PRU Prudential Financial Inc
PPL PPL Corp
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Price
Delayed
$172.86
Day's Change
-0.505 (-0.29%)
Bid
--
Ask
--
B/A Size
--
Day's High
173.85
Day's Low
172.42
Volume
(Light)

Today's volume of 2,084,363 shares is on pace to be much lighter than JNJ's 10-day average volume of 5,173,043 shares.

2,084,363

Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Valuation Ratios

Price/Earnings (TTM)
26.22x
Price/Sales (TTM)
5.15x
Price/Book (MRQ)
6.60x
Price/Cash Flow (TTM)
18.18x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

July 2021
Current Month
15.8M
Previous Month
14.6M
Percent of Float
0.60%
Days to Cover
2.4252 Days

Share Information

JNJ is in a share class of common stock
Float
2.6B
Shares Outstanding
2.6B
Institutions Holding Shares
4,133
66.40%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Alex GorskyChmn.
  • Paulus A. Stoffels
  • Joaquin Boix Duato
  • Joseph J. WolkCFO
  • Peter M. Fasolo

Address

  • 1 Johnson And Johnson Plz
  • New Brunswick, NJ 08933-0001
  • Phone: (732) 524-2455
  • Fax: (732) 214-0332
  • https://www.jnj.com/

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.